12/1
01:23 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/13
07:51 am
crdl
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 [Yahoo! Finance]
Medium
Report
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 [Yahoo! Finance]
10/17
04:44 pm
crdl
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027 [Yahoo! Finance]
Low
Report
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027 [Yahoo! Finance]
9/19
06:25 am
crdl
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Low
Report
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.